主动监测时间是否影响延迟根治性前列腺切除术的病理与肿瘤学结局
本研究纳入1992至2015年间170例 favourable risk、Grade Group 1 前列腺癌患者,因进展为临床显著前列腺癌(Grade Group 2或以上)而接受延迟根治性前列腺切除术(ASRP),并与405例匹配的即刻根治性前列腺切除术患者比较。结果显示两组pT3、切缘阳性及pN1率相当,5年生化复发无生存率分别为85.8%和82.4%(p=0.38),总生存与肿瘤特异生存相当,延迟手术未与不良病理或生化复发相关。
要点
- 主动监测后延迟根治性前列腺切除术的5年肿瘤学结局良好。
- 延迟手术与即刻手术相比,pT3、切缘阳性及pN1率无差异。
- 主动监测时间中位31.0个月未导致不良病理或生化复发风险增加。
核心结论
- 经过一段主动监测后以治愈为目的的根治性前列腺切除术在5年时获得 excellent 的病理和肿瘤学结局。
- 主动监测期与具有相似风险特征的即刻根治性前列腺切除术患者相比,未导致更差的结局。
研究设计与样本
- 回顾性队列研究,纳入1992至2015年Princess Margaret Cancer Centre的170例 favourable risk、Grade Group 1 前列腺癌患者,因进展为临床显著前列腺癌(Grade Group 2或以上)接受延迟根治性前列腺切除术(ASRP)。
- ASRP队列与405例匹配的即刻根治性前列腺切除术队列比较,匹配基于手术前特征。
- 采用logistic回归分析延迟根治性前列腺切除术与根治性前列腺切除术时不良病理的关联,Cox回归分析其与生化复发的关联。
主要发现
- 主动监测至根治性前列腺切除术的中位时间为31.0个月。
- 根治性前列腺切除术时pT3(精囊侵犯、包膜外侵犯)、切缘阳性及pN1率在两组间相当。
- 根治性前列腺切除术后中位随访5.6年,ASRP队列与即刻根治性前列腺切除术队列的5年生化复发无生存率分别为85.8%和82.4%(p=0.38)。
- 两组总生存和肿瘤特异生存相当。
- 回归分析显示延迟根治性前列腺切除术与不良病理结局及生化复发无关。
临床怎么用
- 对于 favourable risk、Grade Group 1 前列腺癌患者,主动监测期间进展后延迟根治性前列腺切除术可获得良好的5年病理和肿瘤学结局。
- 主动监测时间本身不应被视为延迟根治性前列腺切除术的不良预后因素。
局限性
- 研究为回顾性设计,样本来自单一中心。
- 根治性前列腺切除术后中位随访时间为5.6年,长期结局需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pathological and oncologic outcomes of delayed radical prostatectomy following prostate cancer active surveillance are not well established. We determined the pathological and oncologic outcomes of favorable risk, Grade Group 1, prostate cancer managed with active surveillance and progressing to radical prostatectomy for clinically significant prostate cancer (Grade Group 2 or greater). MATERIALS AND METHODS: Between 1992 and 2015, 170 men with favorable risk prostate cancer underwent delayed radical prostatectomy for clinically significant prostate cancer (ASRP) at the Princess Margaret Cancer Centre. Pathological and oncologic outcomes of the ASRP cohort were compared with a matched cohort treated with up-front radical prostatectomy (405) immediately before surgery. Biochemical recurrence-free survival, overall survival and cancer specific survival were compared. We examined the association between delayed radical prostatectomy and adverse pathology at radical prostatectomy and biochemical recurrence using logistic and Cox regression analyses, respectively. RESULTS: Median time spent on active surveillance before radical prostatectomy was 31.0 months. At radical prostatectomy pT3 (extraprostatic extension, seminal vesicle invasion), positive surgical margin and pN1 rates were comparable between the 2 cohorts. Median followup after radical prostatectomy was 5.6 years. The 5-year biochemical recurrence-free survival rate in the ASRP cohort and up-front radical prostatectomy cohort were 85.8% and 82.4%, respectively (p=0.38). Overall survival and cancer specific survival were comparable between the 2 groups. Delayed radical prostatectomy was not associated with adverse pathological outcomes and biochemical recurrence on regression analyses. CONCLUSIONS: Curative intent radical prostatectomy after a period of active surveillance results in excellent pathological and oncologic outcomes at 5 years. A period of active surveillance does not result in inferior outcomes compared to patients with similar risk characteristics undergoing up-front radical prostatectomy.
引用
- Ahmad AE, Richard PO, Leão R, et al. Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy? J Urol. 2020. PMID: 32259466. doi:10.1097/JU.0000000000001070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。